Evidence map›Paper›PMID 33159883›Full record

ArticleAmerican journal of human genetics2020

RLIM Is a Candidate Dosage-Sensitive Gene for Individuals with Varying Duplications of Xq13, Intellectual Disability, and Distinct Facial Features.

Elizabeth E Palmer, Renee Carroll, Marie Shaw, Raman Kumar, Andre E Minoche, Melanie Leffler, Lucinda Murray, Rebecca Macintosh, Dale Wright, Chris Troedson and 21 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 18 institutions in 4 countries.

Elizabeth E PalmerGenetics of Learning Disability Service, Waratah, NSW 2298, Australia; School of Women's and Children's Health, UNSW Medicine, University of New South Wales, Randwick, NSW 2031, Australia; Sydney Children's Hospital, Randwick, NSW 2031, Australia; Kinghorn Centre for Clinical Genomics, Garvan Institute, Darlinghurst, Sydney, NSW 2010, Australia. Electronic address: elizabeth.palmer@health.nsw.gov.au.
Renee CarrollAdelaide Medical School and the Robinson Research Institute, University of Adelaide, Adelaide, SA 5000, Australia.
Marie ShawAdelaide Medical School and the Robinson Research Institute, University of Adelaide, Adelaide, SA 5000, Australia.
Raman KumarAdelaide Medical School and the Robinson Research Institute, University of Adelaide, Adelaide, SA 5000, Australia.
Andre E MinocheSt Vincent's Clinical School, University of New South Wales, Sydney, NSW 2010, Australia.
Melanie LefflerGenetics of Learning Disability Service, Waratah, NSW 2298, Australia.
Lucinda MurrayGenetics of Learning Disability Service, Waratah, NSW 2298, Australia.
Rebecca MacintoshSydney Children's Hospital, Randwick, NSW 2031, Australia.
Dale WrightDiscipline of Genomic Medicine and Discipline of Child & Adolescent Health, University of Sydney, Sydney, NSW 2010, Australia; Department of Cytogenetics, The Children's Hospital at Westmead, Westmead, NSW 2145, Australia.
Chris TroedsonChildren's Hospital at Westmead, Sydney, NSW 2145, Australia.
Fiona McKenzieSchool of Paediatrics and Child Health, University of Western Australia, Perth, WA 6009, Australia; Genetic Services of Western Australia, Perth, WA 6008, Australia.
Sharron TownshendGenetic Services of Western Australia, Perth, WA 6008, Australia.
Michelle WardGenetic Services of Western Australia, Perth, WA 6008, Australia.
Urwah NawazAdelaide Medical School and the Robinson Research Institute, University of Adelaide, Adelaide, SA 5000, Australia.
Anja RavineDepartment of Cytogenetics, The Children's Hospital at Westmead, Westmead, NSW 2145, Australia; Pathwest Laboratory Medicine WA, Perth, WA 6008, Australia.
Cassandra K RunkeGenomics Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, AZ 85259, USA.
Erik C ThorlandGenomics Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, AZ 85259, USA.
Marybeth HummelWest Virginia University School of Medicine, Department of Pediatrics, Section of Medical Genetics Morgantown, WV 26506-9600, USA.
Nicola FouldsWessex Clinical Genetics Services, Southampton SO16 5YA, UK.
Olivier PichonService de génétique médicale - Unité de Génétique Clinique, CHU de Nantes - Hôtel Dieu, Nantes 44093, France.
Bertrand IsidorService de génétique médicale - Unité de Génétique Clinique, CHU de Nantes - Hôtel Dieu, Nantes 44093, France.
Cédric Le CaignecService de génétique médicale, Institut fédératif de Biologie, CHU Hopital Purpan, Toulouse 31059, France.
Bénédicte DemeerCenter for Human Genetics, CLAD Nord de France, CHU Amiens-Picardie, Amiens 80080, France; CHIMERE EA 7516, University Picardie Jules Verne, Amiens 80025, France.
Joris AndrieuxInstitut de Biochimie et Génétique Moléculaire, CHU Lille, Lille 59000, France.
Salam Hadah AlbaraziHospital Center De Saint-Quentin, Saint-Quentin 02321, France.
Ann ByeSchool of Women's and Children's Health, UNSW Medicine, University of New South Wales, Randwick, NSW 2031, Australia; Sydney Children's Hospital, Randwick, NSW 2031, Australia.
Rani SachdevSchool of Women's and Children's Health, UNSW Medicine, University of New South Wales, Randwick, NSW 2031, Australia; Sydney Children's Hospital, Randwick, NSW 2031, Australia.
Edwin P KirkSchool of Women's and Children's Health, UNSW Medicine, University of New South Wales, Randwick, NSW 2031, Australia; Sydney Children's Hospital, Randwick, NSW 2031, Australia.
Mark J CowleyChildren's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Randwick, NSW 2033, Australia.
Mike FieldGenetics of Learning Disability Service, Waratah, NSW 2298, Australia.
Jozef GeczAdelaide Medical School and the Robinson Research Institute, University of Adelaide, Adelaide, SA 5000, Australia; Healthy Mothers, Babies and Children, South Australian Health and Medical Research Institute, Adelaide, SA 5000, Australia. Electronic address: jozef.gecz@adelaide.edu.au.
UNSW Sydney · AUThe University of Adelaide · AUHunter Genetics · AUCentre Hospitalier Universitaire de Nantes · FRChildren's Hospital at Westmead · AUMayo Clinic in Arizona · USServices Australia · AUCentre Hospitalier de Saint-Quentin · FRCentre Hospitalier Universitaire Amiens-Picardie · FRCentre Hospitalier Universitaire de Lille · FRGarvan Institute of Medical Research · AUHôpital Purpan · FRSouth Australian Health and Medical Research Institute · AUSydney Children's Hospital · AUThe University of Sydney · AUThe University of Western Australia · AUWessex Regional Genetics Laboratory · GBWest Virginia University · US

Funding

Wellcome Trust
6 · The paper itself

Abstract

Interpretation of the significance of maternally inherited X chromosome variants in males with neurocognitive phenotypes continues to present a challenge to clinical geneticists and diagnostic laboratories. Here we report 14 males from 9 families with duplications at the Xq13.2-q13.3 locus with a common facial phenotype, intellectual disability (ID), distinctive behavioral features, and a seizure disorder in two cases. All tested carrier mothers had normal intelligence. The duplication arose de novo in three mothers where grandparental testing was possible. In one family the duplication segregated with ID across three generations. RLIM is the only gene common to our duplications. However, flanking genes duplicated in some but not all the affected individuals included the brain-expressed genes NEXMIF, SLC16A2, and the long non-coding RNA gene FTX. The contribution of the RLIM-flanking genes to the phenotypes of individuals with different size duplications has not been fully resolved. Missense variants in RLIM have recently been identified to cause X-linked ID in males, with heterozygous females typically having normal intelligence and highly skewed X chromosome inactivation. We detected consistent and significant increase of RLIM mRNA and protein levels in cells derived from seven affected males from five families with the duplication. Subsequent analysis of MDM2, one of the targets of the RLIM E3 ligase activity, showed consistent downregulation in cells from the affected males. All the carrier mothers displayed normal RLIM mRNA levels and had highly skewed X chromosome inactivation. We propose that duplications at Xq13.2-13.3 including RLIM cause a recognizable but mild neurocognitive phenotype in hemizygous males.

Indexed as

Chromosome DuplicationGene DosageX Chromosome InactivationAdolescentAustraliaChildChild, PreschoolFaceFemaleHemizygoteHeterozygoteHumansIntellectual DisabilityMaleMiddle AgedMonocarboxylic Acid TransportersMonocarboxylic Acid TransportersNerve Tissue ProteinsNEXMIF protein, humanRLIM protein, humanSLC16A2 protein, humanSymportersUbiquitin-Protein Ligasesautismchromosomal duplicationchromosomal microarraydosage sensitive geneintellectual disabilityNEXMIFRLIMTonne-Kalscheuer syndromewhole genome sequencingXq13

Identifiers

PMID33159883
PMCPMC7820564
OpenAlexW3097148435

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.